Treace Medical Concepts (TMCI) Interest Expenses (2020 - 2026)

Treace Medical Concepts' Interest Expenses history runs 7 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• Quarterly Interest Expenses rose 218.84% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 24.06% YoY) and the FY2025 annual result came in at $56.7 million, up 28.51% from the prior year.
• Interest Expenses was $4.2 million for Q1 2026 at Treace Medical Concepts, up from $1.6 million in the prior quarter.
• Across five years, Interest Expenses topped out at $26.8 million in Q1 2022 and bottomed at $1.2 million in Q3 2022.
• A 5-year average of $3.1 million and a median of $1.3 million in 2024 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses plunged 99.39% — and 2026, when it jumped 218.84%.
• Treace Medical Concepts' Interest Expenses stood at $1.3 million in 2022, then retreated by 0.53% to $1.3 million in 2023, then climbed by 20.25% to $1.6 million in 2024, then decreased by 0.13% to $1.6 million in 2025, then surged by 166.92% to $4.2 million in 2026.
• Business Quant data shows TMCI's Interest Expenses at $4.2 million in Q1 2026, $1.6 million in Q4 2025, and $1.3 million in Q3 2025.